Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
CB

NASDAQ · CBLL

CeriBell, Inc. Common Stock

Healthcare · Medical - Devices

$26.58

Down-$1.24 (-4.46%)

Updated Nov 1, 2026, 9:16 PM

SID Score

5.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
757.49M
P/E ratio
-14.33
Dividend yield
0.00%
52-week range
$10.85 – $28.19
Volume
582.65K
Avg. volume
348.13K

Price performance · CBLL

CBLL price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

CBLL closed at $26.58 after 20 trading sessions, up 6.92% for the selected period.

Last close
$26.58
Period change
+6.92%
Period low
$23.15
Period high
$27.82
Daily close
View OHLC price history
CBLL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$27.48$27.61$26.012$26.58582.65K
Oct 29, 2026$27.40$28.19$27.00$27.82405.31K
Oct 28, 2026$27.22$27.60$26.81$27.22742.95K
Oct 27, 2026$27.17$27.71$26.67$27.221.16M
Oct 26, 2026$27.21$27.63$26.98$27.03311.6K
Oct 23, 2026$27.24$27.80$26.29$27.13497.68K
Oct 22, 2026$27.00$27.87$26.765$27.40368.29K
Oct 21, 2026$27.64$28.11$27.01$27.14472.01K
Oct 20, 2026$26.00$27.91$26.00$27.68593.25K
Oct 19, 2026$25.05$26.505$24.62$26.00633.56K
Oct 16, 2026$27.48$27.48$24.86$25.04406.93K
Oct 15, 2026$26.50$27.94$25.85$27.64911.79K
Oct 14, 2026$25.78$26.72$25.00$26.37887.63K
Oct 13, 2026$25.35$26.625$24.895$26.14542.7K
Oct 12, 2026$23.77$25.27$23.27$25.26697.04K
Oct 9, 2026$23.03$23.85$22.895$23.63325.34K
Oct 8, 2026$23.40$23.40$22.62$23.15243.79K
Oct 7, 2026$24.20$24.55$23.43$23.48305.4K
Oct 6, 2026$24.95$25.1031$24.22$24.34241.74K
Oct 5, 2026$23.67$25.045$23.67$24.86239.51K

Latest CBLL news

The latest Smart Investors Daily articles mentioning CBLL.

Stock researchCompany · Overview

CBLL research

Overview

Company profile and research snapshot.

Company profile

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$30.00
Implied upside
—
Analysts
—
CBLL recent ratings
DateFirmRatingTarget
Oct 2, 2026TD CowenBuy—
Sep 11, 2026BTIGBuy—
Aug 18, 2026BTIGBuy—
Aug 11, 2026BTIGBuy—
Aug 11, 2026Canaccord GenuityBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 25, 2026

3 AI Stocks To Own In October 2026

AI risk is suddenly front-page news. Financiers are warning that high valuations and concentrated exposure in artificial intelligence could feed the next market downturn, yet the same technology is quietly reshaping how smaller specialists build tools in automation, data and machine learning. That disconnect is where opportunity often hides. This article highlights three under-the-radar AI-focused small caps that show how targeted exposure can complement a broader portfolio. The three stocks...

Yahoo · Oct 24, 2026

Pfizer And 2 Other AI Healthcare Stocks To Watch

Warning signs around heavily indebted AI infrastructure firms have grown louder after analysts raised the risk of a tech debt spiral, with some newer players struggling to finance data centers and high-end chips. That strain shifts attention toward more grounded uses of AI that address urgent problems such as healthcare. Investors seeking substance over hype may find this article useful. It profiles three AI powered healthcare stocks from our screener. The three stocks covered below are a...

Yahoo · Oct 20, 2026

Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026

SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2026 after the close of trading on Tuesday, November 3, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on November

Yahoo · Oct 18, 2026

CeriBell And These 2 AI Stocks To Watch

America’s planned AI build-out faces funding strains and project delays, yet the race to add computing power has not stopped. When big data centre projects hit financing walls, attention often shifts to smaller, more focused AI players that do not need multi billion dollar budgets to move the needle. This article spotlights three under the radar AI driven US small caps from our screener that could merit a place on your watchlist. The three AI small caps covered next are only a starting...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By